April 9, 2025 - 07:06

US Treasuries experienced a decline for the second consecutive day, following a disappointing auction of $58 billion in three-year government debt. The auction, which aimed to attract buyers for this crucial segment of the debt market, fell short of expectations, raising concerns among investors about the overall health of the economy and the appetite for government bonds.
The lackluster demand was evident as the bid-to-cover ratio, a key indicator of auction interest, dropped significantly. This has led to increased anxiety among market participants, who are now questioning the sustainability of recent bond yields and the potential implications for future monetary policy. Analysts suggest that the weak auction results may signal broader issues, including inflationary pressures and the Federal Reserve's ongoing adjustments to interest rates.
As market sentiment shifts, investors are keeping a close eye on upcoming economic data releases that could further influence the trajectory of US Treasuries and overall market stability.
September 12, 2026 - 00:50
US Tariff Refunds Slow as Government Collects More Than It Pays OutThe flow of tariff refunds from the US government has slowed sharply, with new figures showing the Treasury took in more money from tariffs than it returned to importers for the first time in...
September 11, 2026 - 02:46
Rayonier Advanced Materials’ (RYAM) Pricing Power Is Surging, But Volumes Tell Another StoryRayonier Advanced Materials reported second-quarter results on August 4 for the period ending June 27, showing a mixed picture of financial performance. Net sales reached $376 million, an 18...
September 10, 2026 - 21:54
OpenAI Rolls Out ChatGPT for Financial Services With Major Industry PartnersOpenAI has introduced a version of ChatGPT built specifically for the financial sector, teaming up with several large brokerages and research organizations, including Morgan Stanley and S&P. The...
September 10, 2026 - 04:58
InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate UpdateVancouver-based InMed Pharmaceuticals has released its financial results for the full fiscal year that ended on June 30, 2026, alongside a broader update on its corporate activities. The company,...